Ph.D., Scientific Director – Biochemistry

Renaud Prudent joined Edelris in 2018 as Unit Manager where he sets up the screening technologies unit. He holds a Ph.D. in Chemical Biology from Grenoble University on allosteric kinase inhibitors.

During his post-docs, he managed different screenings in oncology (synthetic lethality, drug enhancers). He has co-authored over 25 publications and patents.

Prior to Edelris, Renaud served as Chief Operational Officer at Cellipse, a drug discovery start-up he cofounded.